Tumor Necrosis Factor-alpha Levels as a Predictor of Clinical Neoadjuvant Chemotherapy Response in a Luminal-type Locally Advance Breast Cancer in Surabaya, Indonesia

• Main Authors: Hanindyo Riezky Beksono (Author), Iskandar Ali (Author), Marjono Dwi Wibowo (Author), Bara Kharisma (Author), Rizki Amalia (Author)
• Formato: Livro
• Publicado em: Wolters Kluwer - Medknow Publications, 2024-03-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Introduction: The prevalence of locally advanced breast cancer (LABC) increases annually, especially in the luminal type. Chemotherapy is one of the treatments used to manage breast cancer. Biomarkers are needed to predict the outcome of chemotherapy, one of which is tumor necrosis factor-alpha (TNF...